Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant 75 mg ODT for Acute Treatment of Migraine in India
NCT07685769Phase 4Recruiting
- Sponsor
- Pfizer
- Start
- Jul 2026
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
A Phase 4 trial of rimegepant in migraine, sponsored by Pfizer. Started Jul 2026; status: recruiting.
02
Drugs
rimegepant
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07685769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07685769.